DCT

1:23-cv-06667

Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialities Ltd

General

Filed

08/21/23

Cause of ActionPatent Infringement

SectorBiotech

Status

Closed (03/01/24)

Patent Owner

NPE (W)

PACER

Nature of Suit835 ANDA

CourtD. New Jersey

Judge	Period	PO Win Rate
Karen M. Williams	08/23/23 - 03/01/24	--

Magistrate

Ann M. Donio

Plaintiff

Party

Name	Ratings
Theravance Biopharma R&D IP LLC NPE	L2 A
Mylan Pharmaceuticals Inc	L5 A
Mylan Ireland Ltd	L5 A
Theravance Biopharma US LLC NPE	L2 A
Theravance Biopharma US Inc NPE	L2 A
Theravance Biopharma Ireland Ltd NPE	L2 A

No Parties

Attorney

Name	Ratings
Womble Bond Dickinson US LLP	L5 A
Mary W. Bourke	L5 A
Dana K. Severance	L5 A
Ben Bourke	-- -- --
SaiberLocal	L4 B
Arnold B. Calmann	L5 E
Katherine Ann Escanlar	L5 E
Rakoczy Molino Mazzochi Siwik LLP	L3 E
Kevin E. Warner	L5 E
William A. Rakoczy	L5 E
Joseph T. Jaros	L3 D
Matthew V. Anderson	L3 E

No Attorneys

Defendant

Party

Name	Ratings
Eugia Pharma Specialities Ltd	L4 E
Lupin Pharmaceuticals Inc	L5 E
Lupin Ltd	L5 E
Cipla USA Inc	L4 E
Eugia US LLC	L4 E
Aurobindo Pharma USA Inc	L4 E
Orbicular Pharmaceutical Technologies Pvt Ltd	L2 E
Mankind Pharma Ltd	L1 D
Lifestar Pharma LLC	L1 D

No Parties

Attorney

Name	Ratings
K&L Gates	L5 B
Tedd W. van Buskirk	L2 E
Loly G. Tor	L1 E
Blank Rome LLP	L4 B
Jay P. Lessler	L1 E
Michael Ray Darbee	-- -- --
Kratz Barry LLP	L2 E
R. Touhey Myer	L4 E
Midlige RichterLocal	-- -- --
James S. Richter	L1 D

No Attorneys